Neutralization of SARS-CoV-2 Omicron BA.2.75 after mRNA-1273 Vaccination.
作者信息
Shen Xiaoying, Chalkias Spyros, Feng Jing, Chen Xing, Zhou Honghong, Marshall Jean-Claude, Girard Bethany, Tomassini Joanne E, Aunins Anne, Das Rituparna, Montefiori David C
机构信息
Duke University Medical Center, Durham, NC.
Moderna, Cambridge, MA.
出版信息
N Engl J Med. 2022 Sep 29;387(13):1234-1236. doi: 10.1056/NEJMc2210648. Epub 2022 Sep 9.
PMID:36083119
Abstract
摘要
相似文献
[1]
Neutralization of SARS-CoV-2 Omicron BA.2.75 after mRNA-1273 Vaccination.
N Engl J Med. 2022-9-29
[3]
[4]
[5]
[6]
[7]
[8]
Audio Interview: A Look at Covid-19 Prevention and Care in 2020.
N Engl J Med. 2020-12-31
[9]
Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.
N Engl J Med. 2021-1-7
[10]
Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants.
N Engl J Med. 2022-4-21
引用本文的文献
[1]
[2]
[3]
[4]
Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants.
NPJ Vaccines. 2023-7-11
[5]
[6]
[7]
Durability of immune responses to mRNA booster vaccination against COVID-19.
J Clin Invest. 2023-5-15
[8]
Immune evasion of neutralizing antibodies by SARS-CoV-2 Omicron.
Cytokine Growth Factor Rev. 2023-4
[9]
[10]
本文引用的文献
[1]
Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant.
Cell Rep Med. 2022-7-19
[2]
SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination.
N Engl J Med. 2022-3-17
[3]
[4]
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines.
Cell Host Microbe. 2021-4-14
Zotero 插件